We are live on ! Find out more
CORT icon

Corcept Therapeutics

226 hedge funds and large institutions have $2.18B invested in Corcept Therapeutics in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 60 increasing their positions, 94 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $1.55B → $2.18B (+$634M)

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

1% more funds holding

Funds holding: 223226 (+3)

9% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 32

4% more call options, than puts

Call options by funds: $23.9M | Put options by funds: $22.9M

5.33% less ownership

Funds ownership: 77.13%71.79% (-5.3%)

36% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 94

Holders
226
Holders Change
+3
Holders Change %
+1.35%
% of All Funds
4%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
35
Increased
60
Reduced
94
Closed
32
Calls
$23.9M
Puts
$22.9M
Net Calls
+$1M
Net Calls Change
-$4.04M
Name Holding Trade Value Shares
Change
Change in
Stake
GT
251
Glenmede Trust
Pennsylvania
-$15K -904 Closed
NICM
252
Neo Ivy Capital Management
New York
-$8K -510 Closed
US Bancorp
253
US Bancorp
Minnesota
-$3K -172 Closed
Rockefeller Capital Management
254
Rockefeller Capital Management
New York
+$105 +5 New
BCA
255
Berman Capital Advisors
Georgia
+$527 +25 New